MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.
about
miR-204 targeting of Ankrd13A controls both mesenchymal neural crest and lens cell migration.Peroxiredoxin 1 - an antioxidant enzyme in cancerThe dual regulatory role of miR-204 in cancerNuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.In silico analysis of microRNA-510 as a potential oncomir in human breast cancerTranscriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.miR-204 is required for lens and retinal development via Meis2 targeting.Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent MechanismsMechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic markerPDEF is a negative regulator of colon cancer cell growth and migrationPDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma.MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.Micro-RNAs and breast cancer.Signatures of prostate-derived Ets factor (PDEF) in cancer.miR-204 is dysregulated in metastatic prostate cancer in vitro.Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.Prediction of miRNA-disease Associations using an Evolutionary Tuned Latent Semantic Analysis.ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
P2860
Q27325851-EFC84626-42D1-49C8-807A-7A1A10F6EA15Q28070359-58A23C91-39EF-4375-896E-7234DB65A3FCQ28078421-A555F81F-DB2C-46AD-A4B3-43A691BD6FCEQ30156863-CD16A878-E9EF-4813-B0C0-FFAA8CD18441Q30499157-2FB8E53E-7585-4588-BA08-8C03B75EABA0Q33739476-C72CE61F-2D80-40F5-8506-43866F2AC63FQ33799676-B402D814-04B2-4050-BA54-683B9CBB9893Q34100520-F38D6609-5737-407D-AE4C-F5CAAD913CCEQ34281856-3982730C-83D0-4A4E-B1F2-3069F43595D6Q34417579-FC806C2C-FED2-42F1-B6E7-115990AB6726Q35034883-8D4B7A1E-00A3-4306-8051-7F78FD593B9CQ35082366-FFB9C687-3872-4A97-978C-BEFE57D72D80Q35089974-26ABA310-0127-4126-A235-3CCFDABFD1EDQ35948104-D8B9CB60-44C2-4297-95ED-410D8167BB0BQ37011750-65ECD4E4-C1ED-4376-A827-D516232C96B3Q37514746-A6F95ED9-57A6-4196-AAD6-88945BFDA15CQ37577131-26B7A838-5C7E-4B33-B7A5-50F75D1A62CAQ37689643-56232615-3067-466C-A962-94CAE5725810Q37764166-FD20EB4E-B7E9-4DB7-94A7-E75E9D71D38CQ38747388-E7BF76D9-9461-4DAA-B39B-45660818877AQ38915627-73C18641-C643-489B-BB91-F236EF7403ABQ39502702-7E155463-A385-462A-97BA-4BA34CB4BB7BQ41592766-B6DBBC8D-3D40-4516-B691-2F93F379B995Q41621167-EE49B397-1BF2-4124-958F-26D85E34D1E4Q58696663-77584307-3418-40A6-8474-0EBF05AD6EBF
P2860
MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-mediated inhibition o ...... tworks in human breast cancer.
@en
MicroRNA-mediated inhibition o ...... tworks in human breast cancer.
@nl
type
label
MicroRNA-mediated inhibition o ...... tworks in human breast cancer.
@en
MicroRNA-mediated inhibition o ...... tworks in human breast cancer.
@nl
prefLabel
MicroRNA-mediated inhibition o ...... tworks in human breast cancer.
@en
MicroRNA-mediated inhibition o ...... tworks in human breast cancer.
@nl
P2093
P2860
P1433
P1476
MicroRNA-mediated inhibition o ...... etworks in human breast cancer
@en
P2093
David P Turner
Dennis K Watson
Omar Moussa
P2860
P304
P356
10.1158/0008-5472.CAN-08-0907
P407
P577
2008-10-01T00:00:00Z